Mesenchymal Stem Cell Therapy for Lung Rejection

19 participants · First posted Jul 4, 2014

Japan Approves Subcutaneous Pembrolizumab, First Subcutaneous Checkpoint Inhibitor in the Country

FDA Advisers Reject New Use for Pacira Nerve Block

STAAR Surgical Shareholders Reject Alcon's $1.6 Billion Acquisition Offer, Deal Terminated